Products for Research Use Only
RegisterLogin

Tibulizumab

CAT: 0804-HY-P99563-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99563-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research[1].
CAS Number
1849636-24-3
Product Name Alternative
LY 3090106
UNSPSC
12352203
Target
Interleukin Related; TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tibulizumab.html
Purity
98.86
Solubility
10 mM in DMSO
Smiles
[Tibulizumab]
Molecular Weight
(201.43 kDa)
References & Citations
[1]Robert J Benschop, et al. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. MAbs. 2019 Aug/Sep;11 (6) :1175-1190.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
IL-17

Alternative Products

CatalogName
E40YR1486Tibulizumab
GTR18337787-01Tibulizumab Antibody
MBS1563855-01Research Grade Tibulizumab
GTR18872234Tibulizumab ELISA Kit
E55B1210Tibulizumab (Reference antibody)
KBI1681KRIBIOLISA™ Tibulizumab ELISA
592249Tibulizumab (IL17A, TNFSF13B, CD257)
GTR18698008-01Tibulizumab Human Monoclonal Antibody
A4001Tibulizumab (Anti-BAFF & IL-17)
F1087-5Anti-BAFF & IL-17A Antibody (Tibulizumab)

Popular Products